ROCKVILLE, MD, Nov. 02, 2022 (GLOBE NEWSWIRE) — MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on the development and commercialization of novel antibody-based therapies for the treatment of cancer, announced today that the company’s management will participate in the following investor conferences in November 2022.
- BMO Biopharma Spotlight Series | Oncology day (virtual). Members of the MacroGenics leadership team will participate in a fireside chat on Wednesday, November 9 at 2:30 p.m. ET. A replay link will be provided after the conference. MacroGenics management will also participate in individual meetings.
- Stifel 2022 Healthcare Conference (New York). MacroGenics President and CEO Scott Koenig, MD, Ph.D., will participate in a fireside chat on Tuesday, November 15 at 10:55 a.m. ET. MacroGenics management will also participate in individual meetings.
- Evercore ISI 5e HEALTHCONx Annual Conference (virtual). MacroGenics President and CEO Scott Koenig, MD, Ph.D., will participate in a fireside chat on Wednesday, November 30 at 8:50 a.m. ET. MacroGenics management will also participate in individual meetings.
Webcasts of the above can be viewed under “Events and Presentations” in the Investor Relations section of MacroGenics’ website at http://ir.macrogenics.com/events.cfm. The Society keeps archived replays of webcasts on its website for 30 days after the conference.
About MacroGenics, Inc.
MacroGenics (the Company) is a biopharmaceutical company focused on the development and commercialization of novel antibody-based therapies for the treatment of cancer. The Company generates its pipeline of product candidates primarily from its proprietary suite of next-generation antibody-based technology platforms, which apply to broad therapeutic areas. The combination of MacroGenics’ technology platforms and protein engineering expertise has enabled the Company to generate promising product candidates and enter into several strategic collaborations with global pharmaceutical and biotechnology companies. For more information, please visit the company’s website at www.macrogenics.com. MacroGenics and the MacroGenics logo are trademarks or registered trademarks of MacroGenics, Inc.
###
